We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$608M
AUM Growth
-$455M
Cap. Flow
-$486M
Cap. Flow %
-79.89%
Top 10 Hldgs %
19.27%
Holding
429
New
65
Increased
103
Reduced
150
Closed
81

Top Buys

Rank Stock Value
1
MMS icon
Maximus
MMS
+$9M
2
ESGR
Enstar Group
ESGR
+$3.12M
3
SYM icon
Symbotic
SYM
+$2.62M
4
MLR icon
Miller Industries
MLR
+$2.62M
5
PD icon
PagerDuty
PD
+$2.45M

Top Sells

Rank Stock Value
1
FANG icon
Diamondback Energy
FANG
+$67.9M
2
OVV icon
Ovintiv
OVV
+$64.5M
3
ERF
Enerplus Corporation
ERF
+$61.9M
4
SM icon
SM Energy
SM
+$48.8M
5
DEN
Denbury Inc.
DEN
+$33.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.7%
2 Technology 16.95%
3 Industrials 13.89%
4 Financials 13.4%
5 Healthcare 12.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVY icon
301
iShares Select Dividend ETF
DVY
$23.8B
$272K 0.04%
2,325
-34,230
-94% -$4.14M
TMCI icon
302
Treace Medical Concepts
TMCI
$265M
$272K 0.04%
10,784
-36,060
-77% -$847K
EHC icon
303
Encompass Health
EHC
$11.3B
$271K 0.04%
+5,001
New +$291K
HOLX
304
DELISTED
Hologic
HOLX
$263K 0.04%
+3,260
New +$262K
AGX icon
305
Argan
AGX
$7.61B
$262K 0.04%
+6,465
New +$254K
DRI icon
306
Darden Restaurants
DRI
$23.4B
$260K 0.04%
1,677
-579
-26% -$85.7K
SMAR
307
DELISTED
Smartsheet Inc.
SMAR
$257K 0.04%
+5,386
New +$234K
FIGS icon
308
FIGS
FIGS
$1.66B
$255K 0.04%
41,142
-68,757
-63% -$529K
CMC icon
309
Commercial Metals
CMC
$7.53B
$253K 0.04%
+5,184
New +$269K
AGL icon
310
Agilon Health
AGL
$1.64B
$249K 0.04%
+420
New +$235K
VST icon
311
Vistra
VST
$53B
$248K 0.04%
+10,348
New +$240K
PRU icon
312
Prudential Financial
PRU
$42.3B
$242K 0.04%
2,928
ITCI
313
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$239K 0.04%
+4,406
New +$213K
ON icon
314
ON Semiconductor
ON
$34.7B
$237K 0.04%
2,878
-671
-19% -$51K
PCOR icon
315
Procore
PCOR
$7.03B
$236K 0.04%
+3,775
New +$221K
LKQ icon
316
LKQ Corp
LKQ
$6.69B
$234K 0.04%
+4,118
New +$232K
ACLS icon
317
Axcelis
ACLS
$3.94B
$234K 0.04%
+1,754
New +$206K
WSC icon
318
WillScot Mobile Mini Holdings
WSC
$4.85B
$230K 0.04%
+4,908
New +$236K
HCKT icon
319
Hackett Group
HCKT
$255M
$228K 0.04%
12,341
-17,430
-59% -$351K
DOCS icon
320
Doximity
DOCS
$3.77B
$218K 0.04%
6,737
+406
+6% +$13.5K
SPTN
321
DELISTED
SpartanNash
SPTN
$215K 0.04%
8,650
-9,044
-51% -$260K
ESAB icon
322
ESAB
ESAB
$5.49B
$214K 0.04%
+3,624
New +$208K
HDSN
323
Hudson Technologies
HDSN
$263M
$212K 0.03%
24,228
-19,114
-44% -$185K
CHWY icon
324
Chewy
CHWY
$8.93B
$210K 0.03%
5,605
-1,117
-17% -$46.2K
GLBE icon
325
Global E Online
GLBE
$6.34B
$209K 0.03%
+6,482
New +$178K

Similar funds

Advisory Research's Q1 2023 Portfolio in Review

As of Q1 2023, Advisory Research held 429 positions worth $608M, down 43% from $1.06B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Advisory Research withdrew a net $486M in Q1 2023, closing 81 positions and reducing 150 holdings. Its most notable exit was Ovintiv, an estimated $64.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 8.6% a quarter earlier, followed by Technology and Industrials.

Against the trend, Advisory Research opened a new position in Maximus worth $9.19M.

  • Advisory Research's largest Q1 2023 buy was Maximus: 116,828 shares worth $9.19M.
  • Advisory Research added most to Enstar Group in Q1 2023, an estimated $3.12M increase.
  • Advisory Research's biggest Q1 2023 reduction was Diamondback Energy, cutting an estimated $67.9M.
  • Advisory Research fully exited Ovintiv in Q1 2023, selling an estimated $64.5M.
  • Advisory Research's ten largest holdings make up 19% of its $608M portfolio in Q1 2023.
  • Advisory Research opened 65 new positions and closed 81 in Q1 2023.
  • Advisory Research's portfolio value fell 43% quarter-over-quarter to $608M.

Based on Advisory Research's 13F filing for Q1 2023, filed 12 May 2023.